Experimental Drug & COVID-19 Pneumonia

Trial Objective

Experimental Drug & COVID-19 PneumoniaResearchers want to know if an experimental drug is safe and beneficial for hospitalized patients that are being treated for COVID-19 Pneumonia. The one-time drug administration will be added into the standard COVID-19 care provided by hospitals.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Adults 18 -years-old and older who are currently admitted to Rose Medical Center in Denver, CO. with the diagnosis of COVID-19 pneumonia.

Age: 18+    Gender: Any Gender


Estimated Time Commitment

Up to 18 weeks

Includes the time a person spends in the hospital, as well as follow-up visits after hospital discharge.



Payment & Reimbursement  

Payment: Not Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Melissa Schwab

Melissa Schwab
303.398.1220

Carmen Edgidio

Carmen Egidio
303.398.1708

Request More Information

Trial Location

National Jewish Health, Rose Medical Center

Trial Sponsors

Pharmaceutical Company

Principal Investigators


Request More Information

Complete this form to learn more about this study and see if you qualify.


*
*
*
*